Published in Medical Device Law Weekly, January 30th, 2005
New prescriptions for Celebrex have fallen by more than half since a government-led study last month showed high doses of it were associated with an increased heart attack risk.
The suit, filed in federal court in Hartford last week by the Colchester-based law firm of Scott & Scott on behalf of investors, claims the company made false and misleading statements about the safety of Celebrex. Those statements kept the company's stock price inflated, according to...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly